NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india) arrow 11814.35 -266.50 -2.21%
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Vimta Labs Limited (NSE: VIMTALABS)

VIMTALABS Technical Analysis
As on 25th Feb 2020 VIMTALABS Share Price closed @ 97.25 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 133.31 & Sell for SHORT-TERM with Stoploss of 98.70 we also expect STOCK to react on Following IMPORTANT LEVELS.


Open 101.40 Change Price %
High 101.50 1 Day -2.20 -2.21
Low 96.00 1 Week -2.80 -2.80
Close 97.25 1 Month -3.50 -3.47
Volume 7842 1 Year -100.20 -50.75
52 Week High 221.00 | 52 Week Low 87.50
NSE INDIA Most Active Stocks
IDEA 3.95 2.60%
YESBANK 35.15 0.57%
SUZLON 2.85 7.55%
GMRINFRA 25.55 0.39%
TATAMOTORS 149.90 -0.50%
ASHOKLEY 80.65 -5.06%
SBIN 326.80 1.19%
IBULHSGFIN 324.70 -1.86%
INDIACEM 87.05 17.24%
SAIL 39.25 0.00%
NSE INDIA Top Gainers Stocks
VIVIDHA 0.30 20.00%
SPYL 0.30 20.00%
NAVINFLUOR 1454.30 20.00%
DPSCLTD 7.60 19.69%
INDIACEM 87.05 17.24%
DNAMEDIA 0.35 16.67%
GTLINFRA 0.40 14.29%
IMPEXFERRO 0.40 14.29%
SURANAT&P 4.00 14.29%
PSL 0.50 11.11%
NSE INDIA Top Losers Stocks
NTL 0.30 -14.29%
NTL 0.30 -14.29%
EUROMULTI 0.35 -12.50%
GRAVITA 57.60 -11.79%
LFIC 54.20 -11.22%
LSIL 0.40 -11.11%
KAUSHALYA 0.40 -11.11%
ISMTLTD 3.55 -10.13%
ZENITHBIR 0.45 -10.00%
BILENERGY 0.45 -10.00%
Daily Charts
Intraday Charts
Whats New @
Free Analysis
VIMTALABS Important Levels Intraday
VIMTALABS Target for Month February
4th UP TARGET164.53
3rd UP TARGET147.01
2nd UP TARGET136.18
1st UP TARGET125.35
1st DOWN TARGET94.45
2nd DOWN TARGET83.62
3rd DOWN TARGET72.79
4th DOWN TARGET55.27
VIMTALABS Weekly Target
4th UP TARGET125.21
3rd UP TARGET117.70
2nd UP TARGET113.06
1st UP TARGET108.42
1st DOWN TARGET95.18
2nd DOWN TARGET90.54
3rd DOWN TARGET85.90
4th DOWN TARGET78.39
VIMTALABS Target for Year 2020
4th UP TARGET548.49
3rd UP TARGET402.33
2nd UP TARGET311.99
1st UP TARGET221.64
1st DOWN TARGET-36.14
2nd DOWN TARGET-126.49
3rd DOWN TARGET-216.83
4th DOWN TARGET-362.99
VIMTALABS Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 47.08 Sideways
MFI (14) MFI is 53.69 Sideways
CCI (20) CCI is -72.60 Sideways
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Short Sell 117.39
10 Day Avg Volume Traded -7.54 % Less then 10 Day Average Volume
VIMTALABS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website
Plot Nos.: 142/2 and 142
IDA Phase II
Hyderabad, 500051
Phone: 91 40 2726 4141
Fax: 91 40 2726 3657
Your Comments and Response on Vimta Labs Limited
VIMTALABS Business Profile
Vimta Labs Limited provides contract research and testing services primarily in India. It offers analytical testing services for food and agriculture products, and drugs and pharmaceuticals, as well as tests water samples for various purposes and specifications. The company also provides environmental assessment services, including site selection and liability studies; environmental impact assessments; environment management plans; carrying capacity based regional studies; environmental audits; solid and hazardous waste management; risk assessments and disaster management plans; occupational health and safety, industrial hygiene; environmental baseline monitoring for air, meteorology, water, soil, noise, ecology, socio-economic, demography, etc.; industrial emission source monitoring; offshore sampling and analysis of marine water and sediments; marine ecological studies; marine impact assessment; rehabilitation and resettlement studies; forestry and ecological studies; geo-technical studies; geological and hydro-geological studies; land use/ land cover studies based on remote sensing; socio-economic studies; due diligence studies; epidemiological studies; wasteland management studies; and study on bio-indicators, as well as offers various other services under environment chemistry. In addition, it provides clinical research services, including Phase-I/ bioequivalence studies, as well as screening and recruitment services; and conducts studies on arious dosage forms, such as tablets, capsules, extended release preparations, gels, jellies, transdermal patches, injectibles, etc. Further, the company offers clinical reference lab services; pre-clinical services, including drug discovery services to pharmaceutical and biotech companies in the areas of pharmacology, DMPK/ADME, toxicology, and bioanalytical; and services in the area of cell and molecular biology. Vimta Labs Limited was founded in 1984 and is based in Hyderabad, India.
2005-2019 All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service